Michigan-based Nemes Rush Group sold 319,503 shares of Viper Energy in the third quarter. The position was worth an estimated $12.18 million as of the previous period. The move marked an exit for ...

An announcement from Dynamic Metals Limited ( (AU:DYM)) is now available. Dynamic Metals Limited has strengthened its balance sheet after directors and management exercised a total of 4 million ...

CytomX has confirmed a Q1'26 readout for additional data from its trial of CX-2051 in colorectal cancer. CTMX also now notes it plans to start combination work with CX-2051 and bevacizumab in Q1'26.

IonQ has demonstrated exceptional topline performance in the recent quarter. The company is also making rapid progress towards creating a fault-tolerant quantum system, a crucial milestone for ...

D-Wave Quantum’s QBTS third-quarter 2025 results show an improvement in the company’s operations. The company reported gross profit of $2.7 million, up 156% year over year. Meanwhile, GAAP gross ...

Editas Medicine (NASDAQ:EDIT) is one of the best gene-editing stocks to buy according to hedge funds. On November 10, 2025, Clear Street raised its price target on Editas Medicine (NASDAQ:EDIT) to ...

Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate therapeutics through its IMP 3 ACT™ platform Combined company has ...

Adjusted operating expenses, Adjusted engineering services costs and Adjusted general and administrative costs are alternative financial measures used by management to evaluate our operating ...

IonQ (IONQ) expects third quarter revenue of $27M and full year 2025 revenue of $91M, more than doubling sales year over year. IonQ raised $1B in equity and holds $1.6B in cash, making it the best ...

IonQ (NYSE: IONQ) shares jumped more than 3.22% in after-hours trading following a historic third quarter that showcased triple-digit revenue growth and record-setting technical milestones. The ...